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Abstract 
Background: Synovial sarcomas commonly occur in the extremities of young adults. A primary occurrence in 
the mediastinum is very rare with only a few reported cases in the world literature. 
Case Report: This paper is about a 47-year-old male who presented with retrosternal chest pain and shortness 
of breath on exertion. Imaging showed an anterior mediastinal mass. Pathological examination of the resected 
mass showed a biphasic neoplasm with a spindle cell component admixed with gland-like elements. The tumor 
showed positive staining with cytokeratin, epithelial membrane antigen, and vimentin confirming the diagnosis 
of a biphasic synovial sarcoma. 
Conclusions: A wide range of neoplasms, both primary and metastatic, occurs in the mediastinum, which 
poses considerable diagnostic difficulties. A synovial sarcoma should always be considered in the differential 
diagnosis, and immunohistochemistry is an important adjuvant tool in this situation. This paper highlights the 
importance of recognizing an unusual presentation of this aggressive neoplasm to aid appropriate clinical 
management. 
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Introduction 
Synovial sarcoma is a mesenchymal tissue cell tumor 
that exhibits epithelial differentiation. Most frequently, 
it arises in the extremities of adolescents and young 
adults (1), while a primary occurrence in the 
mediastinum is quite rare with only a few reported 
cases in the world literature (2). Primary mediastinal 
synovial sarcoma is a malignant tumor, able to invade 
adjacent organs or give distant metastases. Pathological 
examination is crucial to establish the diagnosis, 
whereas clinical presentation and imaging patterns are 
often aspecific and misleading. Herein, we report a 
case of 14 cm primary mediastinal synovial sarcoma, 
diagnosed in a 47-year-old male. 
Case Report 
A 47-year-old man presented with symptoms of 
retrosternal chest pain, not related to physical activity 
or exertion. He also complained of shortness of breath 
on exertion. There was no history of cough, 
hemoptysis, fever, or weight loss. Physical examination 
did not reveal anything significant. His blood 
investigations at presentation revealed hemoglobin 
level of 12.5 g/dl, total leukocyte counts of 
8500 cells/mm
3
, and platelet counts of 360,000/mm
3
. 
His serum electrolytes, renal function tests, and liver 
function tests were within normal range. Germ cell 
tumor markers such as lactate-dehydrogenase, alpha-
fetoprotein, and β-human chorionic gonadotropin 
levels were within normal limits. The chest X-ray 
showed a large mass in left thoracic cavity, adjacent to 
the mediastinum (Figure 1a). Computed tomography 
(CT) scan revealed a 14 cm heterogeneously anterior 
mediastinal mass (Figure 1b).  
 a                                              b 
Figure 1. (a) Chest X-ray showed a large mass in left 
thoracic cavity, (b) computed tomography scan of the chest 
revealed a 14 cm heterogeneously anterior mediastinal mass 
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Figure 2. (a) Tumor removed at sternotomy, (b) histology demonstrating spindle and epithelioid cells 
 
CT guided biopsy was done. It was reported as sarcoma. 
Positron emission tomography (PET) scan was 
performed to exclude any metastatic disease (no other 
foci that may represent metastatic disease). Then, the 
patient underwent median sternotomy and excision of 
tumor was performed. The tumor measured about 14 cm 
× 14 cm × 9.5 cm (Figure 2a). Histologically the tumor 
was composed of spindle cells and glandular epithelial 
structures (Figure 2b). Numerous mitotic figures (more 
than 4/10 high-power field) were seen, and there were 
focal areas of necrosis. Immunohistochemistry 
demonstrated strong positivity for cytokeratins, vimentin 
and focal positivity for epithelial membrane antigen 
(EMA). Mesothelial markers and primary pulmonary 
tumor marker thyroid transcription factor-1 (TTF-1) 
were negative. With the combination of 
histopathological features and immunohistochemical 
findings, a diagnosis of a primary biphasic synovial 
sarcoma of the mediastinum was offered. Post-operative 
recovery was smooth. The patient received adjuvant 
chemotherapy. The patient is on regular follow-up 
without evidence of residual or recurrent disease.  
 
Discussion 
The term synovial sarcoma is a misnomer because the 
tumor does not arise from the synovium; it only 
resembles synovial tissue on light microscopy. It 
appears to arise from multipotent stem cells that are 
capable of differentiating into mesenchymal and/or 
epithelial structures and lack synovial differentiation 
(3,4). Less than 10-20% of synovial sarcoma arise in 
extra-extremity locations (1,5). In general, soft tissue 
sarcomas including angiosarcoma, leiomyosarcoma, 
sarcomatoid mesothelioma, rhabdomyosarcoma, and 
synovial sarcoma, account for < 0.01% of all malignant 
thoracic neoplasms (6). According to data from a large 
population-based study, around 17% of new cases of 
soft tissue sarcomas (including variety of histologic 
subtypes) arise in thoracic locations including the 
pleura, lungs, and the mediastinum with an 
approximate incidence of 6/million populations (7). 
Nevertheless, there are no data that accurately report 
the exact incidence of synovial sarcoma cases that arise 
primarily in the mediastinum. Morphologically, 
synovial sarcomas are divided into monophasic and 
biphasic subtypes. The biphasic variant consists of 
proliferation of bland looking spindle-shaped cells, 
along with evidence of epithelial differentiation. 
Monophasic subtypes on the other hand can show 
either spindle cells only or occasionally epithelial 
component only (8). A poorly differentiated variant of 
synovial sarcoma is also recognized (9). The 
differential diagnosis of a primary synovial sarcoma in 
the mediastinum is complex as a wide array of primary 
and metastatic tumors occur in this site. 
Immunohistochemistry can be very helpful. 
Immunostains are valuable and supportive for the 
diagnosis of a suspected case of synovial sarcoma. The 
expression of epithelial markers in the gland-like 
component and more importantly in the spindle cell 
component supports the diagnosis. EMA is the most 
commonly positive marker among all epithelial 
markers (9). Pan-cytokeratin and cytokeratins 7 and 19 
can also be positive in the epithelial-like component as 
well as the spindle cell component (10). In addition, 
positivity for bcl-2 can be seen in some cases (11). 
Accurate staging of the disease is important for 
appropriate patient management and requires the 
evaluation of the primary tumor and assessment for 
distant disease. Magnetic resonance imaging has been 
the traditional imaging tool for assessment of soft 
tissue masses, but more recently soft tissue sarcomas 
are well recognized as showing increased 18F-fluoro-
2-deoxy-d-glucose uptake in PET (12). Broad surgical 
resection is the cornerstone of therapy. Complete 
resection of the tumor was the overwhelming factor in 
determining survival in a review of primary 
mediastinal sarcomas (13). Radiotherapy is 
recommended with positive margins (14). The place 
for chemotherapy of this tumor is not well defined, and 
in none of the other case, reports were pre-operative 
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chemotherapy given (15). Combination of adriamycine 
and ifosfamide has been used as an adjuvant therapy 
and for recurrences (15). Traditionally, synovial 
sarcoma has been considered to have a poor prognosis 
with metastasis occurring in 50% of the cases. The 
lung is the most common site for metastasis followed 
by lymph nodes and bone. However, not all synovial 
sarcomas share the same dismal outcome anymore. 
Spillane et al. demonstrated that an age > 20 years at 
diagnosis and size > 5 cm were associated with a 
significantly worse prognosis (16,17). However, 
prognosis after aggressive multimodal therapy is good 
and survival up to 14 years has been documented (15). 
As conclusion, the mediastinum is an uncommon site 
of occurrence of synovial sarcoma that occurred in index 
case. Synovial sarcoma must be entertained in the 
differential diagnosis of spindle cell as well as biphasic 
tumors arising in the mediastinum. This case report 
emphasizes the importance of prompt clinical suspicion, 
accurate histopathological diagnosis, and use of 
appropriate immunohistochemical markers in the 
diagnosis of this unusual tumor in an unusual site. 
Aggressive multimodal therapy is recommended, and 
our patient has responded to surgery and chemotherapy. 
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